Global Beta-lactam and Beta-lactamase Inhibitors Market Insights, Forecast to 2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	198 Pages	QYResearch Group	March, 2022	QYR17054829

Best Price Guarantee
Price	from $4,900
Length	198 Pages
Publisher	QYResearch Group
Published Date	March, 2022
SKU	QYR17054829

Global Beta-lactam and Beta-lactamase Inhibitors Market Insights, Forecast to 2028
Market Analysis and Insights: Global Beta-lactam and Beta-lactamase Inhibitors Market

Due to the COVID-19 pandemic, the global Beta-lactam and Beta-lactamase Inhibitors market size is estimated to be worth US$ 27730 million in 2022 and is forecast to a readjusted size of US$ 31119 million by 2028 with a CAGR of 1.94% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Cephalosporins accounting for 26.96% of the Beta-lactam and Beta-lactamase Inhibitors global market in 2021, is projected to value US$ 8344 million by 2028.

Global Beta-lactam and Beta-lactamase Inhibitors Scope and Segment

Beta-lactam and Beta-lactamase Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-lactam and Beta-lactamase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company

Pfizer
Novartis (Sandoz)
TEVA
Merck
AbbVie (Allergan)
Sumitomo Dainippon
Hikma
Aurobindo Pharma
Wockhardt
Lupin Limited
Fresenius Kabi
B. Braun
USantibiotics
Qilu Pharmaceutical
ACS Dobfar
Nichi-Iko (Sagent)
Antibiotice

Segment by Type

Penicillins
Cephalosporins
Carbapenems
Monobactams
Combinations

Segment by Application

Oral
Intravenous

Segment by Region

North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Philippines
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

1 Study Coverage: 1.1 Beta-lactam And Beta-lactamase Inhibitors Product Introduction; 1.2 Market By Type; 1.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028; 1.2.2 Penicillins; 1.2.3 Cephalosporins; 1.2.4 Carbapenems; 1.2.5 Monobactams; 1.3 Market By Application; 1.3.1 Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028; 1.3.2 Oral; 1.3.3 Intravenous; 1.4 Study Objectives; 1.5 Years Considered
2 Executive Summary: 2.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales Estimates And Forecasts 2017-2028; 2.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Estimates And Forecasts 2017-2028; 2.3 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region: 2017 Vs 2021 Vs 2028; 2.4 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region; 2.4.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2017-2022); 2.4.2 Global Sales Beta-lactam And Beta-lactamase Inhibitors By Region (2023-2028); 2.5 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region; 2.5.1 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2017-2022); 2.5.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2023-2028); 2.6 North America; 2.7 Europe; 2.8 Asia-pacific; 2.9 Latin America; 2.10 Middle East & Africa
3 Competition By Manufacturers: 3.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Manufacturers; 3.1.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Manufacturers (2017-2022); 3.1.2 Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Manufacturers (2017-2022); 3.1.3 Global Top 10 And Top 5 Largest Manufacturers Of Beta-lactam And Beta-lactamase Inhibitors In 2021; 3.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Manufacturers; 3.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Manufacturers (2017-2022); 3.2.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Manufacturers (2017-2022); 3.2.3 Global Top 10 And Top 5 Companies By Beta-lactam And Beta-lactamase Inhibitors Revenue In 2021; 3.3 Global Beta-lactam And Beta-lactamase Inhibitors Sales Price By Manufacturers (2017-2022); 3.4 Analysis Of Competitive Landscape; 3.4.1 Manufacturers Market Concentration Ratio (Cr5 And Hhi); 3.4.2 Global Beta-lactam And Beta-lactamase Inhibitors Market Share By Company Type (Tier 1, Tier 2, And Tier 3); 3.4.3 Global Beta-lactam And Beta-lactamase Inhibitors Manufacturers Geographical Distribution; 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size By Type: 4.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Type; 4.1.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Sales By Type (2017-2022); 4.1.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Sales By Type (2023-2028); 4.1.3 Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Type (2017-2028); 4.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Type; 4.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Revenue By Type (2017-2022); 4.2.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Revenue By Type (2023-2028); 4.2.3 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Type (2017-2028); 4.3 Global Beta-lactam And Beta-lactamase Inhibitors Price By Type; 4.3.1 Global Beta-lactam And Beta-lactamase Inhibitors Price By Type (2017-2022); 4.3.2 Global Beta-lactam And Beta-lactamase Inhibitors Price Forecast By Type (2023-2028)
5 Market Size By Application: 5.1 Global Beta-lactam And Beta-lactamase Inhibitors Sales By Application; 5.1.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Sales By Application (2017-2022); 5.1.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Sales By Application (2023-2028); 5.1.3 Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Application (2017-2028); 5.2 Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Application; 5.2.1 Global Beta-lactam And Beta-lactamase Inhibitors Historical Revenue By Application (2017-2022); 5.2.2 Global Beta-lactam And Beta-lactamase Inhibitors Forecasted Revenue By Application (2023-2028); 5.2.3 Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Application (2017-2028); 5.3 Global Beta-lactam And Beta-lactamase Inhibitors Price By Application; 5.3.1 Global Beta-lactam And Beta-lactamase Inhibitors Price By Application (2017-2022); 5.3.2 Global Beta-lactam And Beta-lactamase Inhibitors Price Forecast By Application (2023-2028)
6 North America: 6.1 North America Beta-lactam And Beta-lactamase Inhibitors Market Size By Type; 6.1.1 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028); 6.1.2 North America Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028); 6.2 North America Beta-lactam And Beta-lactamase Inhibitors Market Size By Application; 6.2.1 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028); 6.2.2 North America Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028); 6.3 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Country; 6.3.1 North America Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028); 6.3.2 North America Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028); 6.3.3 United States; 6.3.4 Canada
7 Europe: 7.1 Europe Beta-lactam And Beta-lactamase Inhibitors Market Size By Type; 7.1.1 Europe Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028); 7.1.2 Europe Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028); 7.2 Europe Beta-lactam And Beta-lactamase Inhibitors Market Size By Application; 7.2.1 Europe Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028); 7.2.2 Europe Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028); 7.3 Europe Beta-lactam And Beta-lactamase Inhibitors Market Size By Country; 7.3.1 Europe Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028); 7.3.2 Europe Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028); 7.3.3 Germany; 7.3.4 U.K.; 7.3.5 France; 7.3.6 Italy; 7.3.7 Russia
8 Asia Pacific: 8.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Market Size By Type; 8.1.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028); 8.1.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028); 8.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Market Size By Application; 8.2.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028); 8.2.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028); 8.3 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Market Size By Region; 8.3.1 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2017-2028); 8.3.2 Asia Pacific Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2017-2028); 8.3.3 China; 8.3.4 Japan; 8.3.5 South Korea; 8.3.6 India; 8.3.7 Australia; 8.3.8 Indonesia; 8.3.9 Thailand; 8.3.10 Malaysia; 8.3.11 Philippines
9 Latin America: 9.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Market Size By Type; 9.1.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028); 9.1.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028); 9.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Market Size By Application; 9.2.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028); 9.2.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028); 9.3 Latin America Beta-lactam And Beta-lactamase Inhibitors Market Size By Country; 9.3.1 Latin America Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028); 9.3.2 Latin America Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028); 9.3.3 Mexico; 9.3.4 Brazil; 9.3.5 Argentina
10 Middle East And Africa: 10.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Market Size By Type; 10.1.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Sales By Type (2017-2028); 10.1.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Revenue By Type (2017-2028); 10.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Market Size By Application; 10.2.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Sales By Application (2017-2028); 10.2.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Revenue By Application (2017-2028); 10.3 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Market Size By Country; 10.3.1 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Sales By Country (2017-2028); 10.3.2 Middle East And Africa Beta-lactam And Beta-lactamase Inhibitors Revenue By Country (2017-2028); 10.3.3 Turkey; 10.3.4 Saudi Arabia; 10.3.5 Uae
11 Company Profiles: 11.1 Pfizer; 11.1.1 Pfizer Corporation Information; 11.1.2 Pfizer Description And Business Overview; 11.1.3 Pfizer Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.1.4 Pfizer Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.2 Novartis (Sandoz); 11.2.1 Novartis (Sandoz) Corporation Information; 11.2.2 Novartis (Sandoz) Description And Business Overview; 11.2.3 Novartis (Sandoz) Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.2.4 Novartis (Sandoz) Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.3 Teva; 11.3.1 Teva Corporation Information; 11.3.2 Teva Description And Business Overview; 11.3.3 Teva Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.3.4 Teva Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.4 Merck; 11.4.1 Merck Corporation Information; 11.4.2 Merck Description And Business Overview; 11.4.3 Merck Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.4.4 Merck Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.5 Abbvie (Allergan); 11.5.1 Abbvie (Allergan) Corporation Information; 11.5.2 Abbvie (Allergan) Description And Business Overview; 11.5.3 Abbvie (Allergan) Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.5.4 Abbvie (Allergan) Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.6 Sumitomo Dainippon; 11.6.1 Sumitomo Dainippon Corporation Information; 11.6.2 Sumitomo Dainippon Description And Business Overview; 11.6.3 Sumitomo Dainippon Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.6.4 Sumitomo Dainippon Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.7 Hikma; 11.7.1 Hikma Corporation Information; 11.7.2 Hikma Description And Business Overview; 11.7.3 Hikma Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.7.4 Hikma Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.8 Aurobindo Pharma; 11.8.1 Aurobindo Pharma Corporation Information; 11.8.2 Aurobindo Pharma Description And Business Overview; 11.8.3 Aurobindo Pharma Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.8.4 Aurobindo Pharma Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.9 Wockhardt; 11.9.1 Wockhardt Corporation Information; 11.9.2 Wockhardt Description And Business Overview; 11.9.3 Wockhardt Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.9.4 Wockhardt Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.10 Lupin Limited; 11.10.1 Lupin Limited Corporation Information; 11.10.2 Lupin Limited Description And Business Overview; 11.10.3 Lupin Limited Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.10.4 Lupin Limited Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.11 Fresenius Kabi; 11.11.1 Fresenius Kabi Corporation Information; 11.11.2 Fresenius Kabi Description And Business Overview; 11.11.3 Fresenius Kabi Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.11.4 Fresenius Kabi Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.12 B. Braun; 11.12.1 B. Braun Corporation Information; 11.12.2 B. Braun Description And Business Overview; 11.12.3 B. Braun Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.12.4 B. Braun Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.13 Usantibiotics; 11.13.1 Usantibiotics Corporation Information; 11.13.2 Usantibiotics Description And Business Overview; 11.13.3 Usantibiotics Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.13.4 Usantibiotics Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.14 Qilu Pharmaceutical; 11.14.1 Qilu Pharmaceutical Corporation Information; 11.14.2 Qilu Pharmaceutical Description And Business Overview; 11.14.3 Qilu Pharmaceutical Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.14.4 Qilu Pharmaceutical Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.15 Acs Dobfar; 11.15.1 Acs Dobfar Corporation Information; 11.15.2 Acs Dobfar Description And Business Overview; 11.15.3 Acs Dobfar Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.15.4 Acs Dobfar Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.16 Nichi-iko (Sagent); 11.16.1 Nichi-iko (Sagent) Corporation Information; 11.16.2 Nichi-iko (Sagent) Description And Business Overview; 11.16.3 Nichi-iko (Sagent) Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.16.4 Nichi-iko (Sagent) Beta-lactam And Beta-lactamase Inhibitors Products Offered; 11.17 Antibiotice; 11.17.1 Antibiotice Corporation Information; 11.17.2 Antibiotice Description And Business Overview; 11.17.3 Antibiotice Beta-lactam And Beta-lactamase Inhibitors Sales, Revenue And Gross Margin (2017-2022); 11.17.4 Antibiotice Beta-lactam And Beta-lactamase Inhibitors Products Offered
12 Market Drivers, Opportunities, Challenges Factors Analysis: 12.1 Beta-lactam And Beta-lactamase Inhibitors Industry Trends; 12.2 Beta-lactam And Beta-lactamase Inhibitors Market Drivers; 12.3 Beta-lactam And Beta-lactamase Inhibitors Market Challenges
13 Value Chain And Sales Channels Analysis: 13.1 Value Chain Analysis; 13.2 Beta-lactam And Beta-lactamase Inhibitors Customers; 13.3 Sales Channels Analysis; 13.3.1 Sales Channels; 13.3.2 Distributors
14 Research Findings And Conclusion
15 Appendix: 15.1 Research Methodology; 15.1.1 Methodology/Research Approach; 15.1.2 Data Source; 15.2 Author Details; 15.3 Disclaimer
List Of Tables: Table 1. Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028 (Us$ Million); Table 2. Penicillins Of Current And Historical Uses; Table 3. Cephalosporins Of Current Clinical Utility Or Of Historical Interest; Table 4. Major Manufacturers Of Cephalosporins; Table 5. Carbapenems Of Current Clinical Utility; Table 6. Major Manufacturers Of Carbapenems; Table 7. Carbapenems Of Current Clinical Utility; Table 8. Major Manufacturers Of Monobactams; Table 9. Global Beta-lactam And Beta-lactamase Inhibitors Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028 (Us$ Million); Table 10. Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region: 2017 Vs 2021 Vs 2028 (Us$ Million); Table 11. Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2017-2022) & (M Units); Table 12. Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Region (2017-2022); Table 13. Global Beta-lactam And Beta-lactamase Inhibitors Sales By Region (2023-2028) & (M Units); Table 14. Global Beta-lactam And Beta-lactamase Inhibitors Sales Market Share By Region (2023-2028); Table 15. Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2017-2022) & (Us$ Million); Table 16. Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Region (2017-2022); Table 17. Global Beta-lactam And Beta-lactamase Inhibitors Revenue By Region (2023-2028) & (Us$ Million); Table 18. Global Beta-lactam And Beta-lactamase Inhibitors Revenue Market Share By Region (2023-2028); Table 19. Global Beta-lactam And Beta-lactamase Inhibitors Sales By Manufacturers (2017-2022) & (M Units); Table 20. Global Beta-lactam And Beta-lactamase Inhibitors Sales Share By Manufacturers (2017-2022)